Slide Stainer Market Size To Hit USD 7.91 Billion By 2032 – SNS Insider

(MENAFN- GlobeNewsWire - Nasdaq) Increasing Need for Advanced Diagnostic Procedures and Automation Fuels Market Growth

Pune, Feb. 27, 2025 (GLOBE NEWSWIRE) -- According to SNS Insider, The Slide Stainer Market was valued at USD 4.37 billion in the year 2023 and is projected to be worth USD 7.91 billion by the year 2032, at a CAGR of 6.84% from 2024 to 2032. The global Slide Stainer Market is set to see significant growth, driven by the increasing demand for advanced diagnostic techniques, automation in pathology labs, and a rise in chronic diseases.

Market Analysis

This growth is driven by the rising prevalence of chronic diseases, such as cancer, and the increasing demand for accurate diagnostic tools. The American Cancer Society estimates 1.9 million new cancer cases in the U.S. in 2023, highlighting the need for advanced diagnostics. Automated slide stainers, offering precision and efficiency, are gaining traction in pathology labs. Government initiatives, like the NIH's USD 500 million funding for cancer research, and technological advancements, such as AI integration, are further propelling market expansion. Slide stainers, which automate the staining process, are becoming indispensable in pathology labs due to their ability to enhance precision, reduce human error, and improve workflow efficiency.

Get a Sample Report of Slide Stainer Market@

Key Slide Stainer Companies Profiled

• F. Hoffmann-La Roche Ltd . (Switzerland): [Ventana BenchMark ULTRA, Ventana HE 600]
• Danaher Corporation (US): [Leica ST5020, Leica ST5010]
• PHC Holdings Corporation (Japan): [Tissue-Tek Prisma Plus, Tissue-Tek DRS 2000]
• Thermo Fisher Scientific Inc . (US): [Shandon Varistain Gemini, Shandon Varistain 24-4]
• Agilent Technologies, Inc . (US): [Dako CoverStainer, Dako Autostainer Link 48]
• Merck KGaA (Germany): [Merck HistoStar, Merck SlideStainer]
• Becton, Dickinson and Company (US): [BD PrepStain, BD Cytology Stainer]
• Siemens Healthineers AG (Germany): [Siemens Hematek 3000, Siemens Hematek Slide Stainer]
• Biocare Medical, LLC (US): [intelliPATH FLX, ONCORE Pro]
• ELITechGroup (France): [Aerospray Hematology Slide Stainer, Aerospray Gram Slide Stainer]
• Sakura Finetek USA, Inc. (US): [Tissue-Tek Prisma, Tissue-Tek DRS 2000]
• SLEE medical GmbH (Germany): [MAS Stainer, MTS Stainer]
• Amos Scientific Pty Ltd . (Australia): [Histo-Pro 300, SlideMaster 300]
• MEDITE Medical GmbH (Germany): [TST44 C, TES99]
• CellPath Ltd . (UK): [CellStain, SlideMaster]
• Diapath S.p.A. (Italy): [Donatello Series, Galileo Series]
• Bio SB, Inc . (US): [TintoStainer, PolyDetector Plus]
• Rockland Immunochemicals, Inc . (US): [ImmunoStainer, HistoStain]
• Cell Signaling Technology, Inc . (US): [SignalStain, IHC Autostainer]
• Diagnostic BioSystems, Inc . (US): [AutoStainer, PolyStain]

Slide Stainer Market Report Scope

Report Attributes	Details
Market Size in 2023	US$ 4.37 Billion
Market Size by 2032	US$ 7.91 Billion
CAGR	CAGR of 6.84% From 2024 to 2032
Base Year	2023
Forecast Period	2024-2032
Historical Data	2020-2022
Key Regional Coverage	North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East]), Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America)

Segmentation Insights

By Product

In 2023, the Reagents & Kits segment held the largest revenue share in the market, contributing 60% of revenue. These components form part of the staining process, and demand is being driven by the increasing number of diagnostic tests. Commonly used specialized reagents for techniques such as IHC and H&E staining Green and inexpensive reagents are catching the attention of hospitals and labs. Moreover, the segment's growth is prompted by the rising prevalence of chronic diseases, which demand accurate diagnostic tools. The increasing adoption of automated staining systems in pathology labs is driving growth for this segment of the market, as the increasing demand for high-quality reagents and kits for lab use is also expected to drive the market from this segment.

By Technology

In 2023, Hematoxylin and Eosin (H&E) accounted for the largest revenue share of 29%. With its simplicity, cost-effectiveness, and ability to give high-resolution depiction of virtually all tissues, H&E staining is the golden standard for histopathology. Currently, it is widely used in cancer diagnostics and research. Automated Hematoxylin and Eosin Stains Automated Hematoxylin and Eosin (H&E) staining systems are becoming increasing popular and are available, offering both consistency and efficiency within high-volume laboratories. Increasing number of cancer patients and need for accurate and precise diagnosis of tissues are fuelling demand. In addition, technological advancements, such as novel staining protocols and incorporation with digital pathology systems, are contributing to the increasing uptake of H&E staining technology.

By Application

The Disease Diagnostics segment accounted for 64% of revenue in 2023, driven by the increasing burden of chronic diseases like cancer and infectious diseases. This is essential for accurate tissue analysis, which is crucial for early and accurate diagnosis, and that is where the slide stainer comes in. According to the WHO, the number of people diagnosed worldwide with cancer could increase by 47% by 2040, highlighting a significant demand for novel diagnostic approaches to further identify patients at risk of developing the disease. Automated slide stainers are optimal in workflow efficiency and minimize human error thus making them a compulsory equipment in pathology labs. Increasing focus on preventive healthcare, as well as early detection of diseases, are expected to propel the demand for slide stainers in diagnostic applications further.

By End-Use

In 2023, the Hospitals and Diagnostics Laboratories segment held the highest market share at 34%, These are primary end-users as a result of the number of diagnostic tests performed. Moreover, the development of advanced staining equipment, skilled workforce, and government funding for healthcare infrastructure are some of the significant drivers of market growth. Another contributor to demand is the rise in specialized diagnostic centers and outpatient clinics. With the growing need for diagnostic accuracy and streamlined workflows, hospitals and labs are increasingly choosing automated slide stainers. The growing prevalence of chronic diseases along with the need for economic diagnostic solutions further propels the growth of the segment.

For A Detailed Briefing Session with Our Team of Analysts, Connect with Us Now@

Slide Stainer Market Segmentation

By Product

• Reagents & Kits
  • Stains
  • Probes
  • Diluents & Buffers
  • Blocking Sera & Reagents
  • Mounting Media, Fixative Reagents, and Embedded Media
  • Antibodies
• Equipment
  • Automated and Semi-automated Slide Stainer
  • Manual Staining Set
• Consumables & Accessories

By Technology

• Hematoxylin and Eosin
• Immunohistochemistry
• Special Stains
• Cytology
• Microbiology
• In-situ Hybridization
• Hematology

By Application

• Disease Diagnostics
  • Breast Cancer
  • Lymphoma
  • Prostate Cancer
  • Non-small Lung Cancer
  • Gastric Cancer
  • Others
• Medical Research

By End-use

• Hospitals and Diagnostics Laboratories
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Others

Regional Analysis

In 2023, North America dominated the slide stainer market, accounting for 40% of the global revenue share. Advanced healthcare infrastructure, high healthcare expenditure, and the presence of leading market players drive the growth of the region. The U.S. is a major player, investing even more in cancer research and diagnostics. Slide stainers are essential diagnostic tools, especially given that the American Cancer Society estimates that 1.9 million new cancer cases were diagnosed in the United States in 2023.

The Asia-Pacific region is anticipated to record the highest growth in the 2024-2032 period, owing to advancement in healthcare infrastructure and government initiatives to improve diagnostic capabilities. Investments in modernizing healthcare systems are being made in countries such as China, India, and Japan. For example, the slide stainer market uncovered lucrative opportunities owing to the Indian government's National Health Mission (NHM) which focuses on enhancing the diagnostic services in rural population.

Recent Developments

• In 2023, Thermo Fisher Scientific launched a next-generation automated slide stainer with enhanced precision and faster processing times, catering to the growing demand for high-throughput diagnostic solutions.
• In January 2024, Roche Diagnostics received regulatory approval for its AI-integrated next-generation slide stainer, which analyzes stained slides in real time for higher accuracy in pathology diagnostics.

Buy a Single-User PDF of Slide Stainer Market Analysis & Outlook Report 2024-2032@

Table of Contents – Major Key Points

1. Introduction

2. Executive Summary

3. Research Methodology

4. Market Dynamics Impact Analysis

5. Statistical Insights and Trends Reporting

5.1 Incidence and Prevalence of Diseases Requiring Histopathology (2023-2032)

5.2 Global and Regional Slide Stainer Adoption Rates (2023-2032)

5.3 Device Shipment Volume and Installed Base (2020-2032)

5.4 Average Cost per Slide Stainer and Market Price Trends (2023-2032)

5.5 Regulatory Compliance and Standards Adoption (2023-2032)

5.6 Healthcare Spending on Slide Stainers (Government, Commercial, Private) (2023-2032)

6. Competitive Landscape

7. Slide Stainer Market by Product

8. Slide Stainer Market by Technology

9. Slide Stainer Market by Application

10. Slide Stainer Market by End-use

11. Regional Analysis

12. Company Profiles

13. Use Cases and Best Practices

14. Conclusion

Access Complete Report Details of Slide Stainer Market Analysis & Outlook 2024-2032@

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)

MENAFN27022025004107003653ID1109257804